US Stock MarketDetailed Quotes

CHGCY Chugai Pharmaceutical (ADR)

Watchlist

16.030
-0.760-4.53%

15min DelayClose Apr 24 16:00 ET

52.75BMarket Cap25.13P/E (TTM)

Chugai Pharmaceutical (ADR) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

-24.11%236.95B

-11.78%1.11T

-37.56%273.81B

14.48%257.9B

13.50%267.42B

-13.35%312.24B

26.00%1.26T

36.07%438.5B

-21.58%225.28B

6.41%235.61B

Operating revenue

-24.11%236.95B

-11.78%1.11T

-37.56%273.81B

14.48%257.9B

13.50%267.42B

-13.35%312.24B

26.00%1.26T

36.07%438.5B

-21.58%225.28B

6.41%235.61B

Cost of revenue

-51.79%72.95B

-13.22%413.31B

-56.76%92.06B

13.26%78.26B

14.83%91.66B

32.25%151.33B

40.84%476.25B

92.58%212.91B

-33.69%69.1B

17.29%79.82B

Gross profit

1.92%164B

-10.90%698.06B

-19.43%181.75B

15.02%179.64B

12.82%175.76B

-34.57%160.91B

18.42%783.48B

6.55%225.59B

-14.68%156.19B

1.59%155.79B

Operating expense

2.41%64.13B

3.49%258.89B

-20.94%60.18B

23.02%72.96B

13.06%63.14B

6.30%62.62B

4.36%250.17B

4.77%76.11B

-2.65%59.3B

-1.40%55.85B

Selling and administrative expenses

7.47%22.59B

12.05%112.58B

0.02%30.76B

15.82%27.54B

43.65%33.26B

-7.77%21.02B

-1.89%100.48B

-11.73%30.75B

-3.77%23.78B

0.34%23.16B

-Selling and marketing expense

7.47%22.59B

12.05%112.58B

0.02%30.76B

15.82%27.54B

43.65%33.26B

-7.77%21.02B

31.18%100.48B

26.32%30.75B

28.83%23.78B

29.26%23.16B

Research and development costs

-3.53%41.36B

16.87%174.87B

-7.46%41.86B

24.15%45.57B

31.79%44.57B

26.58%42.87B

8.98%149.63B

19.64%45.23B

1.40%36.71B

0.76%33.82B

Other operating expenses

114.59%185M

-44,726.56%-28.56B

-9,817.97%-12.44B

86.53%-160M

-1,203.82%-14.69B

-156.36%-1.27B

--64M

--128M

---1.19B

---1.13B

Operating profit

1.60%99.87B

-17.65%439.17B

-18.66%121.58B

10.11%106.69B

12.68%112.62B

-47.44%98.3B

26.41%533.31B

7.49%149.47B

-20.69%96.89B

3.34%99.94B

Net non-operating interest income expense

-98.90%15M

51,733.33%4.65B

311.79%1.11B

142.48%788M

78.53%1.38B

-14.63%1.37B

-132.14%-9M

40.30%-526M

-667.28%-1.86B

150.16%773M

Non-operating interest income

-98.90%15M

----

76.27%1.39B

-15.24%1.37B

----

--788M

Non-operating interest expense

----

-55.74%27M

-50.00%8M

-53.33%7M

-40.00%9M

-85.71%2M

27.08%61M

33.33%16M

25.00%15M

Total other finance cost

----

-8,888.46%-4.67B

-320.00%-1.12B

-143.21%-795M

----

31.58%-52M

-41.31%510M

642.77%1.84B

----

Other net income (expense)

Other non- operating income (expenses)

----

15.98%-2.13B

3.09%267M

----

Income before tax

0.23%99.89B

-16.44%443.82B

-17.78%122.69B

13.09%107.48B

13.19%113.99B

-46.48%99.66B

26.65%531.17B

7.78%149.22B

-20.60%95.03B

3.81%100.71B

Income tax

-2.57%25.49B

-24.49%118.35B

-32.64%31.48B

9.80%29.9B

8.70%30.8B

-51.94%26.16B

34.67%156.74B

18.03%46.74B

-19.12%27.24B

7.78%28.34B

Net income

1.23%74.4B

-13.08%325.47B

-11.00%91.21B

14.42%77.57B

14.94%83.19B

-44.22%73.5B

23.58%374.43B

3.68%102.48B

-21.18%67.8B

2.34%72.38B

Net income continuous Operations

1.23%74.4B

-13.08%325.47B

-11.00%91.21B

14.42%77.57B

14.94%83.19B

-44.22%73.5B

23.58%374.43B

3.68%102.48B

-21.18%67.8B

2.34%72.38B

Minority interest income

Net income attributable to the parent company

1.23%74.4B

-13.08%325.47B

-11.00%91.21B

14.42%77.57B

14.94%83.19B

-44.22%73.5B

23.58%374.43B

3.68%102.48B

-21.18%67.8B

2.34%72.38B

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

1.23%74.4B

-13.08%325.47B

-11.00%91.21B

14.42%77.57B

14.94%83.19B

-44.22%73.5B

23.58%374.43B

3.68%102.48B

-21.18%67.8B

2.34%72.38B

Basic earnings per share

1.21%22.61

-13.10%98.915

-11.01%27.715

14.41%23.575

14.93%25.285

-44.25%22.34

23.52%113.82

3.61%31.145

-21.22%20.605

2.28%22

Diluted earnings per share

1.21%22.605

-13.08%98.9

-11.00%27.715

14.42%23.57

14.94%25.28

-44.23%22.335

23.57%113.785

3.66%31.14

-21.19%20.6

2.33%21.995

Dividend per share

0.23%38.5119

-5.49%18.6381

6.25%19.8738

4.41%38.4244

-9.17%19.7204

23.94%18.704

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	-24.11%236.95B	-11.78%1.11T	-37.56%273.81B	14.48%257.9B	13.50%267.42B	-13.35%312.24B	26.00%1.26T	36.07%438.5B	-21.58%225.28B	6.41%235.61B
Operating revenue	-24.11%236.95B	-11.78%1.11T	-37.56%273.81B	14.48%257.9B	13.50%267.42B	-13.35%312.24B	26.00%1.26T	36.07%438.5B	-21.58%225.28B	6.41%235.61B
Cost of revenue	-51.79%72.95B	-13.22%413.31B	-56.76%92.06B	13.26%78.26B	14.83%91.66B	32.25%151.33B	40.84%476.25B	92.58%212.91B	-33.69%69.1B	17.29%79.82B
Gross profit	1.92%164B	-10.90%698.06B	-19.43%181.75B	15.02%179.64B	12.82%175.76B	-34.57%160.91B	18.42%783.48B	6.55%225.59B	-14.68%156.19B	1.59%155.79B
Operating expense	2.41%64.13B	3.49%258.89B	-20.94%60.18B	23.02%72.96B	13.06%63.14B	6.30%62.62B	4.36%250.17B	4.77%76.11B	-2.65%59.3B	-1.40%55.85B
Selling and administrative expenses	7.47%22.59B	12.05%112.58B	0.02%30.76B	15.82%27.54B	43.65%33.26B	-7.77%21.02B	-1.89%100.48B	-11.73%30.75B	-3.77%23.78B	0.34%23.16B
-Selling and marketing expense	7.47%22.59B	12.05%112.58B	0.02%30.76B	15.82%27.54B	43.65%33.26B	-7.77%21.02B	31.18%100.48B	26.32%30.75B	28.83%23.78B	29.26%23.16B
Research and development costs	-3.53%41.36B	16.87%174.87B	-7.46%41.86B	24.15%45.57B	31.79%44.57B	26.58%42.87B	8.98%149.63B	19.64%45.23B	1.40%36.71B	0.76%33.82B
Other operating expenses	114.59%185M	-44,726.56%-28.56B	-9,817.97%-12.44B	86.53%-160M	-1,203.82%-14.69B	-156.36%-1.27B	--64M	--128M	---1.19B	---1.13B
Operating profit	1.60%99.87B	-17.65%439.17B	-18.66%121.58B	10.11%106.69B	12.68%112.62B	-47.44%98.3B	26.41%533.31B	7.49%149.47B	-20.69%96.89B	3.34%99.94B
Net non-operating interest income expense	-98.90%15M	51,733.33%4.65B	311.79%1.11B	142.48%788M	78.53%1.38B	-14.63%1.37B	-132.14%-9M	40.30%-526M	-667.28%-1.86B	150.16%773M
Non-operating interest income	-98.90%15M	----	----	----	76.27%1.39B	-15.24%1.37B	----	----	----	--788M
Non-operating interest expense	----	-55.74%27M	-50.00%8M	-53.33%7M	-40.00%9M	-85.71%2M	27.08%61M	33.33%16M	25.00%15M	25.00%15M
Total other finance cost	----	-8,888.46%-4.67B	-320.00%-1.12B	-143.21%-795M	----	----	31.58%-52M	-41.31%510M	642.77%1.84B	----
Other net income (expense)
Other non- operating income (expenses)	----	----	----	----	----	----	15.98%-2.13B	3.09%267M	----	----
Income before tax	0.23%99.89B	-16.44%443.82B	-17.78%122.69B	13.09%107.48B	13.19%113.99B	-46.48%99.66B	26.65%531.17B	7.78%149.22B	-20.60%95.03B	3.81%100.71B
Income tax	-2.57%25.49B	-24.49%118.35B	-32.64%31.48B	9.80%29.9B	8.70%30.8B	-51.94%26.16B	34.67%156.74B	18.03%46.74B	-19.12%27.24B	7.78%28.34B
Net income	1.23%74.4B	-13.08%325.47B	-11.00%91.21B	14.42%77.57B	14.94%83.19B	-44.22%73.5B	23.58%374.43B	3.68%102.48B	-21.18%67.8B	2.34%72.38B
Net income continuous Operations	1.23%74.4B	-13.08%325.47B	-11.00%91.21B	14.42%77.57B	14.94%83.19B	-44.22%73.5B	23.58%374.43B	3.68%102.48B	-21.18%67.8B	2.34%72.38B
Minority interest income
Net income attributable to the parent company	1.23%74.4B	-13.08%325.47B	-11.00%91.21B	14.42%77.57B	14.94%83.19B	-44.22%73.5B	23.58%374.43B	3.68%102.48B	-21.18%67.8B	2.34%72.38B
Preferred stock dividends
Other preferred stock dividends	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	1.23%74.4B	-13.08%325.47B	-11.00%91.21B	14.42%77.57B	14.94%83.19B	-44.22%73.5B	23.58%374.43B	3.68%102.48B	-21.18%67.8B	2.34%72.38B
Basic earnings per share	1.21%22.61	-13.10%98.915	-11.01%27.715	14.41%23.575	14.93%25.285	-44.25%22.34	23.52%113.82	3.61%31.145	-21.22%20.605	2.28%22
Diluted earnings per share	1.21%22.605	-13.08%98.9	-11.00%27.715	14.42%23.57	14.94%25.28	-44.23%22.335	23.57%113.785	3.66%31.14	-21.19%20.6	2.33%21.995
Dividend per share	0	0.23%38.5119	-5.49%18.6381	0	6.25%19.8738	0	4.41%38.4244	-9.17%19.7204	0	23.94%18.704
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall